Overview of Current and Upcoming Strategies Implied for the Therapy of Type 2 Diabetes Mellitus

Publisher： Bentham Science Publishers

E-ISSN： 1875-6417|10|4|275-282

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.10, Iss.4, 2014-07, pp. : 275-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alterations of Glucose Metabolism in Type 2 Diabetes Mellitus. An Overview

By Bonadonna Riccardo C.  

Reviews in Endocrine and Metabolic Disorders, Vol. 5, Iss. 2, 2004-05 ,pp. : 89-97

Springer Publishing Company

Access to resources Recommend Favorite

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials

By  

Current Diabetes Reviews, Vol. 13, Iss. 4, 2017-07 ,pp. : 405-423

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Basis of Type 2 Diabetes Mellitus: Implications for Therapy

By Wolford Johanna K.  

Treatments in Endocrinology, Vol. 3, Iss. 4, 2004-01 ,pp. : 257-267

Adis International

Access to resources Recommend Favorite

Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitus

By Forst Thomas   Pfützner Andreas  

Expert Review of Endocrinology and Metabolism, Vol. 8, Iss. 1, 2013-01 ,pp. : 21-35

Informa Healthcare

Access to resources Recommend Favorite

Disease overview - Type 2 diabetes

By Clark Richard  

Drugs in Context Primary Care Part D: Endocrinology and Gastroenterology, Vol. 1, Iss. 1, 2004-02 ,pp. : 3-12

CSF Medical Communications Ltd

Access to resources Recommend Favorite